Neurogenic Bladder Clinical Trial
Official title:
Incidence of Urinary Tract Infection and Germ Identification After Urodynamic Investigation in Patients With Spinal Cord Injury
Verified date | December 2016 |
Source | Balgrist University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Switzerland: Ethikkommission |
Study type | Interventional |
The purpose of this study is to evaluate the incidence of urinary tract infection after urodynamic investigation and to identify the involved germs.
Status | Completed |
Enrollment | 317 |
Est. completion date | May 2012 |
Est. primary completion date | May 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - Patients with neurogenic lower urinary tract dysfunction with scheduled urodynamic investigation - No antibiotic treatment - Written informed consent Exclusion Criteria: - Pregnancy and breastfeeding - Current antibiotic therapy |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
Switzerland | Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital | Zürich |
Lead Sponsor | Collaborator |
---|---|
Balgrist University Hospital |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of urinary tract infection following urodynamic investigation | every patient receives the urine examination before the urodynamic investigation and hospitalized patients additionally 3 days later and ambulatory patients in case of urinary tract infection | 3 days after urodynamic investigation | No |
Secondary | Name and number of identified bacterial species | 30 minutes before examination | No | |
Secondary | Number of hospitalized and number of ambulatory patients with infection of the lower urinary tract | 3 days after examination | No | |
Secondary | Incidence of urinary tract infection before urodynamic investigation | every patient receives the urine examination before the urodynamic investigation to detect a potentially urinary tract infection | 30 minutes before urodynamic investigation | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02978638 -
Electrical Stimulation for Continence After Spinal Cord Injury
|
N/A | |
Enrolling by invitation |
NCT06429631 -
The Effect of CIC Education on QOL and Compliance With Mobile Application in Individuals With Spinal Cord Injury.
|
N/A | |
Completed |
NCT03573726 -
Use of a Diurnal Indwelling Urethral Catheter to Improve Quality of Life
|
N/A | |
Recruiting |
NCT06059066 -
Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction
|
N/A | |
Completed |
NCT01429090 -
Bioavailability of Vagantin® Coated Tablets Relative to an Oral Methantheline Bromide Solution
|
Phase 1 | |
Recruiting |
NCT05587101 -
Neurogenic Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis
|
||
Terminated |
NCT03843073 -
Connected Catheter- Safety and Effectiveness Study
|
N/A | |
Terminated |
NCT04059159 -
Connected Catheter - Safety and Effectiveness Study
|
N/A | |
Completed |
NCT05861024 -
Urinary Calculi After Bladder Augmentation in Children
|
||
Completed |
NCT05858840 -
Urinary Artificial Sphincter in Children
|
||
Completed |
NCT04074616 -
Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation
|
N/A | |
Completed |
NCT05683938 -
GentleCathâ„¢ Air Intermittent Catheter Smartwatch Real Life Pilot Study
|
||
Completed |
NCT04543552 -
A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
|
||
Active, not recruiting |
NCT06247033 -
Efficacies of Different Managements in Patients With Overactive Bladder With Stroke
|
N/A | |
Withdrawn |
NCT01305681 -
Bacterial Properties With LoFric® Catheters During Clean Intermittent Catheterization
|
Phase 1/Phase 2 | |
Recruiting |
NCT04248322 -
Qualitative Assessment of the Impact of TTNS on QOL and Participation
|
||
Recruiting |
NCT05301335 -
Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study
|
N/A | |
Recruiting |
NCT04924569 -
Continence Care Registry
|
||
Completed |
NCT01716624 -
Botox Versus Oxybutynin as First Line Treatment for the Poorly Compliant Pediatric Neurogenic Bladder
|
Phase 3 | |
Recruiting |
NCT04373512 -
Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury
|
Phase 2 |